<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045463"><TermName>interleukin-11</TermName><TermPronunciation>(in-ter-LOO-kin...)</TermPronunciation><TermDefinition><DefinitionText>One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. Interleukin-11 is made by support cells in the bone marrow. It causes the growth of several types of blood cells. Oprelvekin (interleukin-11 made in the laboratory) is used as a biological response modifier to increase the number of platelets, especially in patients receiving chemotherapy for cancer. Interleukin-11 is a type of cytokine.  Also called IL-11.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705495" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-11&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705494" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-11&quot;" language="es" id="_4"/><SpanishTermName>interleucina-11</SpanishTermName><SpanishTermDefinition><DefinitionText>Pertenece a un grupo de proteínas relacionadas que elaboran los leucocitos (glóbulos blancos) y otras células en el cuerpo. Las células de sostén de la médula ósea elaboran la  interleucina-11. Causa la formación de varios tipos de células sanguíneas. La oprelvecina (interleucina-11 que se produce en el laboratorio) se  usa como modificador de la respuesta biológica para aumentar el número de plaquetas, sobre todo en pacientes de cáncer que reciben quimioterapia.  La interleucina-11 es un tipo de citocina. También se llama IL-11.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2010-07-19</DateLastModified></GlossaryTerm>
